Related Experiment Video
Updated: Mar 3, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity
Thashi Chang1, Patrick Waters, Mark Woodhall
1*Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka †Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Recurrent optic neuritis (ON) associated with myelin oligodendrocyte glycoprotein (MOG) antibodies requires immunosuppression for remission. This South Asian case highlights MOG antibody disease globally.
Area of Science:
- Neuroimmunology
- Ophthalmology
Background:
- Optic neuritis (ON) can be an initial sign of central nervous system autoimmune diseases like multiple sclerosis (MS) and neuromyelitis optica (NMO).
- Some ON cases involve antibodies against myelin oligodendrocyte glycoprotein (MOG).
Observation:
- A 50-year-old Sri Lankan female presented with recurrent, steroid-responsive ON.
- Neurological investigations were unremarkable, but MOG antibodies were positive, and AQP4 antibodies were negative.
- The patient experienced relapses upon steroid discontinuation but remained relapse-free with low-dose steroids and mycophenolate mofetil.
Findings:
- Recurrent ON can occur independently of MS and NMO in the presence of MOG antibodies.
- Long-term immunosuppression, including steroids and mycophenolate mofetil, is effective in maintaining remission.
Implications:
- This case expands the understanding of MOG antibody disease occurrence worldwide.
- Effective management strategies for MOG antibody-associated ON may involve steroid-based immunosuppression.
More Related Videos
08:03Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
12:23Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment